Health & Fitness News February 6, 2024 Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes February 6, 2024 Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease February 6, 2024 Wall Street says Big Tech needs to take a breather after huge run. Here's our take February 6, 2024 Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue February 5, 2024 King Charles diagnosed with cancer February 5, 2024 Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply February 2, 2024 Fourth-quarter earnings are shaping up to be the best of 2023, but there's a catch February 2, 2024 Here are Jim Cramer’s rapid-fire takeaways on 6 stocks in the news Friday February 2, 2024 Bristol Myers Squibb results top estimates as new drugs post strong sales growth « Previous 1 2 3 4 … 14 15 16 17 18 19 20 21 22 Next »
February 6, 2024 Eli Lilly results blow past estimates on strong Zepbound launch, surging Mounjaro revenue